Home  »  Environment  »  Lilly to supply 614,000 additional doses of bamlanivimab and etesevimab to the U.S. Government for the treatment or post-exposure prevention of COVID-19

Lilly to supply 614,000 additional doses of bamlanivimab and etesevimab to the U.S. Government for the treatment or post-exposure prevention of COVID-19

INDIANAPOLIS, Nov. 2, 2021 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced an additional purchase by the U.S. government for bamlanivimab with etesevimab for administration together. This neutralizing antibody therapy is authorized for emergency use for the treatment of…

About the Author

has written 39059 stories on this site.

«
»
Copyright © 2010 Business and Corporate News.